Blog

Global Think Tank on Steatotic Liver Disease

by Brandon Tudor | June 7, 2025 | News | 0 Comments

Recent news from Barcelona: As a function of the very first Global Think Tank on Steatotic Liver...

MASLD and Type 2 Diabetes

by Brandon Tudor | June 5, 2025 | News | 0 Comments

An article recently published in Diabetes Care highlights the significant interplay between...

Improving QOL For Decompensated Cirrhosis Patients

by Brandon Tudor | June 3, 2025 | News | 0 Comments

Consider the article titled "Decompensated Liver Cirrhosis Care" from Gastroenterology &...

Great video from the Liver Education Advocates event (featuring Gina Madison) in Pittsburgh on March 2, 2025, where folks received a liver scan via the Mindray Hepatus 6. https://youtu.be/Dz1eg-DWkS0?si=qV32VZj4VKaD6BMS SOURCE: WTAE Hepatus 6 Summary:A new era for...

MASH Drives Increasing Chronic Liver Diseases

by Brandon Tudor | Mar 4, 2025 |

In the 02/25/25 article "MASH Drives Increasing Global Incidence of Cirrhosis, Chronic Liver Diseases" in HCP Live, the conclusion is that focused efforts targeted at the metabolic risk factors to curb the rising incidence of MASH, increasing linkage to care for viral...

Compensated MASH Cirrhosis: Resmetirom-Effect

by Brandon Tudor | Mar 2, 2025 |

From the AJMC Journal 02/27/2025: "At 2 years, participants in the compensated MASH cirrhosis treatment arm of the MAESTRO-NAFLD-1 trial experienced a statistically significant 6.7 kPa reduction in liver stiffness from baseline." Per the article by Rose McNulty-- At 2...

Quick Links

Our Team
About 
Careers
Contact